Richard J. Durbin headshot
At a Glance
Seat
U.S. Senator from Illinois
Born
November 21, 1944
Age 81
Phone
(202) 224-2152
Office
711 Hart Senate Office Building Washington, DC 20510, Washington 20515
Congress Member Profile|U.S. Senator|Democrat|Illinois

Richard J. Durbin

Richard Joseph Durbin is an American politician and attorney serving as the senior United States senator from the state of Illinois, a seat he has held since 1997. A member of the Democratic Party, Durbin is in his fifth Senate term and has served since 2005 as the Senate Democratic Whip and since 2025 as the Senate minority whip. He is the longest-serving Democratic whip since the position was established in 1913. Durbin chaired the Senate Judiciary Committee from 2021 to 2025, and led the Ketanji Brown Jackson Supreme Court nomination hearings.

Source: WikipediaView full (CC BY-SA)
Voting Record — 789
Yes34%
No63%
Present0%
Not Voting3%
Party align93%
Cross-party6%
SoupScore
District Map

Senate District (Statewide)

U.S. Census Bureau boundary data.
Richard J. Durbin headshot
Richard J. Durbin
U.S. SenatorDemocratIllinois
SoupScore
Richard J.'s ATmosphere Activity
20 recent posts · 127 sponsored · 341 cosponsored
View profile

Recent ATmosphere posts, sponsorships, and cosponsorships.

President Trump’s $400 million private jet gifted from Qatar is blatantly unconstitutional. Attorney General Bondi had a clear conflict of interest in the matter, but the Department has outrageously put ethical matters in the hands of two political appointees beholden to her. We need answers.
Pres. Trump promised to end the war in Ukraine on day one. More than 100 days into his term, Russia continues to kill Ukrainian civilians. I’m introducing a bill to prohibit U.S. recognition of any Ukrainian territory seized by Russia—reaffirming our commitment to the Ukrainian people.
Ms. María Corina Machado has bravely continued to push for respect of the legitimate 2024 Venezuelan presidential election results. Today, I had the honor of speaking with her to remind her that the Venezuelan people’s democratic aspirations are not forgotten in the U.S. Senate.
Megan Dwyer is a fourth generation farmer from Coal Valley, Illinois. She serves as Director of Conservation and Nutrient Stewardship for the Illinois Corn Growers Association. Her exceptional background made her a valuable witness at today’s Agriculture Committee hearing on conservation.
I shared as much with Mr. Edlow, and I asked him important questions on workforce cuts to USCIS staff, DACA, and family separation. I look forward to hearing more from him under oath.
I will continue calling out their cruelty and illegality, as well as stress the need for serious bipartisan immigration reform to deliver for American communities and businesses that rely on immigrants.
The Trump Administration’s anti-immigrant record is a shameful betrayal of American values. The Administration continues to ignore due process and wrongfully divert resources away from processing applications for lawful immigration status.
I just met with Joseph Edlow, President Trump’s pick to be Director of the U.S. Citizenship and Immigration Services. He’s helped force out critical staff and gut the agency, which is responsible for keeping our lawful immigration system functioning. My thoughts. A THREAD.
I sat down with the Community Bankers Association of Illinois to discuss how community banks provide essential financial services while reinvesting in the neighborhoods they serve.
The mere notion that the President would cravenly accept a $400 million attempt to win favor from a foreign power is beyond the pale and reeks of corruption. I’m joining Senator Schatz to reaffirm what our Constitution makes clear – no President should receive gifts from a foreign power.
Imagine if this was a member of your family. It’s time to legislate again to lower prescription drug costs. President Trump can hold press conferences, but Congress must deliver.
Sen. DURBIN: You walk into a patient’s room to say that *essential cancer therapy* is held up by a PBM. How do you explain that? Medical oncologist: We’re well-trained to tell a patient bad news. But since I’ve started, there are more conversations about affording medications.
Kids as young as 12 can be recruited to work on tobacco farms where they're exposed to toxic tobacco plants containing nicotine. I introduced legislation to put an end to this disgraceful labor practice and protect these kids before it’s too late.
While President Trump basks in the spotlight with Saudi royalty, I hope he will also urge them to release human rights lawyer Waleed Abu al-Khair and allow writer Raif Badawi to finally reunite with his family in Canada.
There’s more we can do to lower prescription drug prices. Tackle direct-to-consumer advertising. Pass PBM reform. Investigate abusive practices by Big Pharma. All should be bipartisan pushes.
Democrats capped the price of insulin at $35 per month, set a $2000 limit on seniors’ out-of-pocket prescription drug expenses, and allowed for price negotiation under Medicare. President Trump talks about it, but Democrats delivered. And not a single Republican voted for it.
Naturally, President Trump’s first trip abroad is not about the nation’s interests, but his dubious business interests. This week’s visit includes three countries—Saudi Arabia, Qatar, and UAE—where Trump has active business deals that benefit him and his family.
Scott Air Force Base, including the 932nd Airlift Wing, is critical to our nation’s military readiness. I met with Lt. Gen. Healy, Chief of the U.S. Air Force Reserve, to discuss how Congress can best support our service members as they carry out their mission.
SoupScore Breakdown
Loading analysis metrics…
Voting History
789 total votes
ExpandCollapse

Recent roll calls with party-majority context so it is easier to scan how this member tends to vote.

DateBillQuestionPositionParty MajAlign?Result
2025-10-01Confirm nomineeNONONomination Confirmed (52-45)
2025-10-01End debateNONOCloture Motion Agreed to (52-47)
2025-10-01H.R. 5371 (119th)End filibuster to begin debateNONOCloture on the Motion to Proceed Rejected (55-45, 3/5 majority required)
2025-10-01S. 2882 (119th)End filibuster to begin debateYESYESCloture on the Motion to Proceed Rejected (47-53, 3/5 majority required)
2025-09-30H.R. 5371 (119th)Final passageNONOBill Defeated (55-45, 3/5 majority required)
2025-09-30S. 2882 (119th)Final passageYESYESBill Defeated (47-53, 3/5 majority required)
2025-09-29S. 2806 (119th)End filibuster to begin debateNONOCloture on the Motion to Proceed Rejected (37-61, 3/5 majority required)
2025-09-29Confirm nomineeNONONomination Confirmed (54-45)
2025-09-29End debateNONOCloture Motion Agreed to (54-45)
2025-09-19Confirm nomineeNOT_VOTINGNONomination Confirmed (47-43)
2025-09-19End debateNONOCloture Motion Agreed to (47-45)
2025-09-19H.R. 5371 (119th)Final passageNONOBill Defeated (44-48, 3/5 majority required)
2025-09-19S. 2882 (119th)Final passageYESYESBill Defeated (47-45, 3/5 majority required)
2025-09-18Confirm nomineeNONONomination Confirmed (51-47)
2025-09-17End debateNONOCloture Motion Agreed to (52-47)
2025-09-17Decision of the Chair PN12-19 and PN25-28 and PN12-45 and PN22-1 and PN22-2 and PN22-5 and PN22-27 and PN22-20 and PN22-21 and PN26-8 and PN26-34 and PN26-35 and PN55-41 and PN22-4 and PN22-8 and PN22-19 and PN26-1 and PN22-23 and PN25-40 and PN26-7 and PN26-19 and PN26-31 and PN60-3 and PN26-44 and PN25-2 and PN55-16 and PN60-9 and PN60-10 and PN129-8 and PN26-45 and PN141-37 and PN141-7 and PN141-28 and PN12-22 and PN25-21 and PN22-3 and PN26-22 and PN13-5 and PN22-24 and PN25-33 and PN141-18 and PN150-5 and PN345-16 and PN55-42 and PN54-6 and PN54-7 and PN55-45 and PN55-25YESYESDecision of Chair Not Sustained (47-52)
2025-09-17Motion to Reconsider PN55-25 and PN55-45 and PN54-7 and PN54-6 and PN55-42 and PN345-16 and PN150-5 and PN141-18 and PN25-33 and PN22-24 and PN13-5 and PN26-22 and PN22-3 and PN25-21 and PN12-22 and PN141-28 and PN141-7 and PN141-37 and PN26-45 and PN129-8 and PN60-10 and PN60-9 and PN55-16 and PN25-2 and PN26-44 and PN60-3 and PN26-31 and PN26-19 and PN26-7 and PN25-40 and PN22-23 and PN26-1 and PN22-19 and PN22-8 and PN22-4 and PN55-41 and PN26-35 and PN26-34 and PN26-8 and PN22-21 and PN22-20 and PN22-27 and PN22-5 and PN22-2 and PN22-1 and PN12-45 and PN12-19 and PN25-28NONOMotion to Reconsider Agreed to (51-47)
2025-09-17End debateNONOCloture Motion Rejected (51-48, 3/5 majority required)
2025-09-16S. Con. Res. 22 (119th)Begin considerationNONOMotion to Proceed Rejected (36-62)
2025-09-16S.J. Res. 60 (119th)Begin considerationYESYESMotion to Proceed Rejected (47-51)
2025-09-15Confirm nomineeNONONomination Confirmed (48-47)
2025-09-15End debateNONOCloture Motion Agreed to (50-44)
2025-09-15S. Res. 377 (119th)Approve resolutionNONOResolution Agreed to (51-44)
2025-09-11S. Res. 377 (119th)End debateNONOCloture Motion Agreed to (53-43)
2025-09-11S. Res. 377 (119th)Decision of the Chair S.Res. 377YESYESDecision of Chair Not Sustained (45-53)
2025-09-11S. Res. 377 (119th)Motion to Reconsider S.Res. 377NONOMotion to Reconsider Agreed to (52-45)
2025-09-11S. Res. 377 (119th)End debateNONOCloture Motion Rejected (52-47, 3/5 majority required)
2025-09-10S. 2296 (119th)Kill the motionNONOMotion to Table Agreed to (51-49)
2025-09-09S. Res. 377 (119th)Begin considerationNONOMotion to Proceed Agreed to (53-45)
2025-09-09S. Res. 377 (119th)Kill the motionNONOMotion to Table Agreed to (53-46)
2025-09-09Confirm nomineeNONONomination Confirmed (53-45)
2025-09-09End debateNONOCloture Motion Agreed to (53-44)
2025-09-09Confirm nomineeNONONomination Confirmed (49-46)
2025-09-09End debateNONOCloture Motion Agreed to (51-46)
2025-09-09Confirm nomineeNONONomination Confirmed (52-45)
2025-09-08Confirm nomineeNONONomination Confirmed (50-43)
2025-09-04S. 2296 (119th)Begin considerationYESYESMotion to Proceed Agreed to (83-13)
2025-09-04End debateNONOCloture Motion Agreed to (53-46)
2025-09-04End debateNONOCloture Motion Agreed to (53-45)
2025-09-02S. 2296 (119th)End filibuster to begin debateYESYESCloture on the Motion to Proceed Agreed to (84-14, 3/5 majority required)
2025-08-02Confirm nomineeYESNONomination Confirmed (71-23)
2025-08-02Confirm nomineeYESNomination Confirmed (72-22)
2025-08-02Confirm nomineeNONONomination Confirmed (59-35)
2025-08-02Confirm nomineeNONONomination Confirmed (52-42)
2025-08-02Confirm nomineeNONONomination Confirmed (50-45)
2025-08-02Confirm nomineeYESYESNomination Confirmed (78-17)
2025-08-02End debateYESYESCloture Motion Agreed to (76-19)
2025-08-02Confirm nomineeNONONomination Confirmed (50-45)
2025-08-02End debateNONOCloture Motion Agreed to (51-45)
2025-08-02Confirm nomineeYESNONomination Confirmed (52-44)

Alignment stats consider only votes where a clear yes/no majority existed for the legislator's party. Cross-party marks divergence where the vote matched the opposite party majority. ↔ indicates cross-party divergence.

← PrevPage 6 / 16Next →